Communications
Finally, a third cascade sequence may be initiated from ortho-
substituted aniline system VIII by acid catalysis, leading,
through fleeting intermediates IX–XI, to tryptamine XII, a
well known building block for many intents and purposes.[5]
The implementation of this plan by using N-Boc aniline
(1a) as a starting material is shown in Scheme 2. Thus,
Figure 1. X-ray derived ORTEP drawings of compounds 1c and 1d
drawn at the 50% probability level.
The generality and scope of this new methodology are
demonstrated by the examples shown in Table 1. Thus, in
addition to aniline itself (Table 1, entry 1), a number of
substituted anilines, including meta- (Table 1, entries 2 and 7)
and para-substituted anilines (Table 1, entries 3–6) were
successfully employed as starting materials leading to an
array of heterocyclic systems, including tryptamine 2e, whose
structure is related to the antipsychotic agents psilocin and
psilocybin.[10,11] Furthermore, the sequence is tolerant of
chlorine and fluorine atoms (Table 1, entries 3 and 4) as well
as trifluoromethyl groups (Table 1, entries 6 and 7), note-
worthy features for medicinal chemistry applications. Naph-
thyl (Table 1, entry 8) and biphenyl (Table 1, entry 9) deriv-
atives also enter the cascade sequence, permitting further
expansion of the scope and generality of the method. Whereas
in situ N-silylation[8] was necessary for the procurement of
free indole tryptamines, N-methylated spirocarbamate 10c
Scheme 2. Synthesis of ortho-substituted anilines 1b and 1d, spiro-
heterocycle 1c, and tryptamines 1e and 1 f. Reagents and conditions:
a) tBuLi (2.4 equiv), Et2O, ꢀ108C, 4 h; b) LaCl3·2LiCl (0.33m in THF,
1.3 equiv), ꢀ708C, 5 min; then A (1.0m in THF, 1.2 equiv), ꢀ70!
258C, 1 h, 1b (75%); c) tBuOK (0.1 equiv), THF, 708C, 4 h, 1c (90%
from 1b; 72% from 1a); d) tBuOK (1.2 equiv), TBSCl or TIPSCl
(1.2 equiv), THF, 258C, 1 h; then LDA (1.0m in THF, 5.0 equiv),
ꢀ50!ꢀ308C, 2 h, 1d (77%); e) TFA/CH2Cl2 (1:10), 0!258C, 2 h, 1e
(98%) or HCl (conc., 1 drop), CH2Cl2, 0!258C, 2 h, 1 f (98%).
TBS=tert-butyldimethylsilyl; TIPS=triisopropylsilyl; TFA=trifluoroace-
tic acid.
treatment of 1a with tBuLi in ether (ꢀ108C, 4 h) and
subsequent sequential addition of LaCl3·2 LiCl (ꢀ708C,
5 min)[6] and N-Boc pyrrolidin-3-one (A)[7] (ꢀ708C) fur-
nished, upon warming to room temperature and aqueous
workup, aniline derivative 1b in 75% yield. The latter
compound was converted into spiro-heterocycle 1c in 90%
yield upon exposure to catalytic amounts of tBuOK
(10 mol%; THF, 708C, 4 h). Alternatively, spiro-heterocycle
1c could be directly obtained from intermediate 1a in 72%
yield upon addition of catalytic amounts of tBuOK (10 mol%;
THF, 708C, 4 h) to the reaction mixture prior to the workup.
The latter observation elevates the cascade sequence from 1a
to a convenient, one-pot operation for the preparation of
spirocycle 1c. Exposure of carbamate 1c to tBuOK and
TBSCl (or TIPSCl)[8] with subsequent addition of LDA gave,
after work up with aqueous NH4Cl, ortho-substituted aniline
1d in 77% yield. Finally, treatment of the labile ortho-
substituted aniline 1d with TFA in CH2Cl2 afforded trypt-
amine 1e in 98% yield, whereas the use of concentrated HCl,
instead of TFA, led to the N-Boc protected tryptamine
derivative 1 f (98% yield).
Scheme 3. Construction of Corey and co-workers’ tryptamine 11 f.
Reagents and conditions: a) Boc2O (1.2 equiv), DMAP (1.0 equiv),
CH2Cl2, 258C, 2 h; then reflux in tBuOH, 6 h; b) NaH (1.5 equiv), MeI
(2.0 equiv), THF, 258C, 2 h, 11b (62%); c) iPrMgCl·LiCl (1.0m in THF,
1.1 equiv), THF, ꢀ708C, 2 h; then LaCl3·2LiCl (0.33m in THF,
1.1 equiv), ꢀ708C, 1 h; then A (1m in THF, 1.0 equiv), ꢀ70!258C,
1 h, 11c (78%); d) TFA (0.1 equiv), CH2Cl2, 08C, 1 h, 11d (96%);
e) LDA (1.0m in THF, 1.1 equiv), ꢀ50!ꢀ308C, 3 h, 11e (92%); f)
TFA (0.1 equiv), CH2Cl2, 0!258C, 2 h, 11 f (96%). DMAP=4-dimethyl-
aminopyridine; LDA=lithium diisopropylamide.
Heterocycles 1c (m.p. 176–1778C, EtOAc) and 1d (m.p.
124–1258C, EtOAc) afforded crystals suitable for X-ray
crystallographic analysis that proved their structure beyond
question[9] (see ORTEP drawings, Figure 1).
4218
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2008, 47, 4217 –4220